Zoetis Slips as Investors Await November Earnings Report

Zoetis shares fell 1.05% to $69.10 in the latest trading session, while the S&P 500 rose 0.2%. The Dow and Nasdaq each gained 0.04%.

The animal-health company’s shares lost 8.32% over the past month, compared with a 1.75% decline for the Medical sector and a 0.35% drop for the S&P 500.

Zoetis is scheduled to report earnings on November 5. Zacks Consensus Estimates put quarterly earnings at $1.52 per share, down 10.59% from a year earlier, and revenue at $2.31 billion, down 3.66%.

For the full year, Zacks estimates earnings of $6.20 per share and revenue of $9.24 billion. Those would be declines of 3.28% and 2.45%, respectively, from the previous year.